Bay Colony Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,813
| Closed | -$366K | – | 518 |
|
|
2025
Q4 | $366K | Sell |
3,813
-1
| -0% | -$97 | 0.04% | 342 |
|
|
2025
Q3 | $363K | Buy |
+3,814
| New | +$351K | 0.04% | 345 |
|
|
2024
Q3 | – | Sell |
-2,589
| Closed | -$204K | – | 453 |
|
|
2024
Q2 | $204K | Sell |
2,589
-58
| -2% | -$4.75K | 0.03% | 385 |
|
|
2024
Q1 | $231K | Sell |
2,647
-81
| -3% | -$6.91K | 0.04% | 341 |
|
|
2023
Q4 | $225K | Sell |
2,728
-4,327
| -61% | -$330K | 0.04% | 325 |
|
|
2023
Q3 | $553K | Buy |
7,055
+187
| +3% | +$15.7K | 0.13% | 159 |
|
|
2023
Q2 | $605K | Buy |
6,868
+4,310
| +168% | +$371K | 0.15% | 145 |
|
|
2023
Q1 | $203K | Sell |
2,558
-1,146
| -31% | -$93.4K | 0.05% | 307 |
|
|
2022
Q4 | $288K | Sell |
3,704
-1,193
| -24% | -$96.7K | 0.08% | 254 |
|
|
2022
Q3 | $395K | Buy |
4,897
+1,112
| +29% | +$99.9K | 0.12% | 175 |
|
|
2022
Q2 | $350K | Sell |
3,785
-83
| -2% | -$8.41K | 0.09% | 214 |
|
|
2022
Q1 | $429K | Sell |
3,868
-3,359
| -46% | -$355K | 0.1% | 195 |
|
|
2021
Q4 | $748K | Sell |
7,227
-2,929
| -29% | -$339K | 0.21% | 116 |
|
|
2021
Q3 | $1.27M | Buy |
10,156
+172
| +2% | +$22.3K | 0.42% | 72 |
|
|
2021
Q2 | $1.24M | Buy |
9,984
+1,638
| +20% | +$206K | 0.41% | 75 |
|
|
2021
Q1 | $986K | Sell |
8,346
-137
| -2% | -$16.1K | 0.38% | 80 |
|
|
2020
Q4 | $994K | Sell |
8,483
-3,259
| -28% | -$359K | 0.53% | 57 |
|
|
2020
Q3 | $1.22M | Buy |
11,742
+1,032
| +10% | +$104K | 0.76% | 36 |
|
|
2020
Q2 | $982K | Buy |
10,710
+2,859
| +36% | +$274K | 0.71% | 44 |
|
|
2020
Q1 | $708K | Buy |
7,851
+792
| +11% | +$84.3K | 0.64% | 50 |
|
|
2019
Q4 | $855K | Sell |
7,059
-40
| -0.6% | -$4.39K | 0.56% | 49 |
|
|
2019
Q3 | $771K | Buy |
7,099
+3,106
| +78% | +$324K | 0.52% | 62 |
|
|
2019
Q2 | $389K | Buy |
3,993
+4
| +0.1% | +$365 | 0.25% | 114 |
|
|
2019
Q1 | $359K | Buy |
3,989
+673
| +20% | +$60.2K | 0.24% | 114 |
|
|
2018
Q4 | $302K | Buy |
+3,316
| New | +$310K | 0.26% | 97 |
|
|
2018
Q3 | – | Sell |
-1,036
| Closed | -$89K | – | 623 |
|
|
2018
Q2 | $89K | Buy |
+1,036
| New | +$86.5K | 0.06% | 266 |
|
Other funds holding MDT
Bay Colony Advisors's MDT Position: Q1 2026 in Review
Bay Colony Advisors sold out of Medtronic (MDT) in Q1 2026, closing a stake of 3,813 shares — an estimated $366K sold.
Bay Colony Advisors first reported a position in MDT in Q2 2018 and held it in 26 quarters. The position peaked at $1.27M in Q3 2021. 2,244 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Bay Colony Advisors reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
- Bay Colony Advisors sold 3,813 Medtronic shares in Q1 2026, an estimated $366K.
- Bay Colony Advisors first reported a position in Medtronic in Q2 2018 and held it in 26 quarters.
- Bay Colony Advisors's Medtronic position peaked at $1.27M in Q3 2021.
- 2,244 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Bay Colony Advisors's 13F filing for Q1 2026, filed 5 May 2026.